News24 News24 | Weight loss jabs skyrocket in SA: Can generics make GLP-1s affordable by 2027?
The high cost of patented GLP-1s and absence of generics remain a major impediment to access in SA, where the medicines are unavailable in the public sector and often unaffordable.